Aspiriant LLC’s Apple AAPL Stock Holding History

Aspiriant LLC’s Portfolio AAPL Stock Details AAPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-500	Closed	-$68K	–	233
2021 Q2	$68K	Buy	+500	New	+$64.8K	﹤0.01%	233

Other funds holding AAPL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Aspiriant LLC's AAPL Position: Q2 2026 in Review

Aspiriant LLC increased its Apple (AAPL) stake by 2.4% in Q2 2026, buying an estimated $1.85M and bringing the position to 278,110 shares worth $80.5M. The position accounts for 1.99% of the portfolio, ranked #11.

Aspiriant LLC first reported a position in AAPL in Q3 2013 and has held it in 52 quarters since. 6,119 funds tracked by Wall St. Rank hold AAPL as of Q2 2026.

Aspiriant LLC held 278,110 shares of Apple worth $80.5M as of Q2 2026.
Aspiriant LLC bought 6,456 Apple shares in Q2 2026, an estimated $1.85M.
Apple made up 1.99% of Aspiriant LLC's portfolio in Q2 2026, its #11 holding.
Aspiriant LLC first reported a position in Apple in Q3 2013 and has held it in 52 quarters since.
6,119 funds tracked by Wall St. Rank held Apple as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.